脑膜炎球菌监测澳大利亚:报告期为2024年10月1日至12月31日
Monica M Lahra1,2, Tiffany R Hogan1,
1The World Health Organization Collaborating Centre for STI and AMR and Neisseria Reference Laboratory, NSW Health Pathology, Microbiology, Prince of Wales Hospital, Randwick, NSW 2031, Australia.
Communicable diseases intelligence (2018)
|July 30, 2025
概括
季度报告现在包括侵入性脑膜炎球菌病 (IMD) 病例数和关键抗生素的抗菌素耐药性数据. 年度报告提供了对IMD实验室确认的全面分析.
科学领域:
- 公共卫生监督 公共卫生监督
- 传染病流行病学 传染病流行病学
- 微生物学 微生物学
背景情况:
- 侵入性脑膜炎球菌病 (IMD) 仍然是一个重大的公共卫生问题.
- 监测疾病趋势和抗菌素耐药性对于有效的控制策略至关重要.
研究的目的:
- 通过包括抗菌素耐药性 (AMR) 信息来加强IMD数据的报告.
- 提供IMD流行病学和耐药性模式的及时更新.
主要方法:
- 使用季度报告来追踪按司法管辖区和血清组的IMD病例数量.
- 在2024年扩大数据收集,以纳入特定抗生素的抗菌素耐药性测试结果 (塞夫特里亚克松,青素,西普罗夫洛克萨,利芬辛).
- 引用AMSP年度报告进行全面的实验室确认分析.
主要成果:
- 季度报告现在提供IMD病例数和血清组数据的描述.
- 开始于2024年,将包括对塞夫特里亚克松,青素,西普罗夫洛克萨和利芬素的抗菌耐药性数据.
- AMSP的年度报告包含对实验室确认的IMD病例的详细年度分析.
结论:
- 增强的季度报告提供了更全面的IMD监测数据.
- 纳入AMR数据对于指导治疗建议和公共卫生干预至关重要.
- 通过年度报告进行持续监测,确保对IMD流行病学有充分的了解.
更多相关视频
09:11Capsular Serotyping of Streptococcus pneumoniae by Latex Agglutination
Published on: September 25, 2014
22.0K
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
18.4K
相关概念视频
01:26Principles of Disease Surveillance
182
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
182
01:19Pharmacovigilance
996
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
996